Ƶ

Kellee Parker
No Rating Available
(Learn About Our Rating System)

Kellee Parker, DO, MCR

Languages spoken: English

Clinical Locations

Primary Children's Hospital

Salt Lake City
801-662-1000

  • Dr. Parker received her medical degree from Rocky Vista Ƶ, completed her Pediatric residency and Pediatric Hematology and Oncology Fellowship at Oregon Ƶ & Science Ƶ. She also received additional training in clinical research through the Masters in Clinical Research program at Oregon Ƶ & Science Ƶ.


    Dr. Parker is currently an Assistant Professor of Pediatrics at the Ƶ of Utah and is in the Division of Pediatric Hematology/Oncology. She is a member of the Leukemia and Lymphoma team at the Ƶ of Utah and Primary Children’s Hospital.


    Dr. Parker’s clinical interests include care of Ƶren with leukemia, lymphoma and various other Ƶhood cancers. She is also interested in the long-term care of patients that have survived Ƶhood cancer. Her research interests include improved care for Ƶhood cancer survivors and their families and decision-making for enrollment in clinical trials within pediatric oncology.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

  • Dr. Parker received her medical degree from Rocky Vista Ƶ, completed her Pediatric residency and Pediatric Hematology and Oncology Fellowship at Oregon Ƶ & Science Ƶ. She also received additional training in clinical research through the Masters in Clinical Research program at Oregon Ƶ & Science Ƶ.


    Dr. Parker is currently an Assistant Professor of Pediatrics at the Ƶ of Utah and is in the Division of Pediatric Hematology/Oncology. She is a member of the Leukemia and Lymphoma team at the Ƶ of Utah and Primary Children’s Hospital.


    Dr. Parker’s clinical interests include care of Ƶren with leukemia, lymphoma and various other Ƶhood cancers. She is also interested in the long-term care of patients that have survived Ƶhood cancer. Her research interests include improved care for Ƶhood cancer survivors and their families and decision-making for enrollment in clinical trials within pediatric oncology.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Assistant Professor (Clinical)
    Academic Divisions Hematology/Oncology
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

    Education history

    Graduate Training Ƶ Experiences Research Training - Ƶ of New Mexico Certificate
    Graduate Training Basic Certificate in Quality & Safety - Institute for Ƶcare Improvement Certification
    Graduate Training Oregon Ƶ & Science Ƶ M.C.R.
    Fellowship Pediatric Hematology/Oncology - Oregon Ƶ & Science Ƶ Fellow
    Residency Pediatrics - Oregon Ƶ & Science Ƶ Resident
    Professional Medical Osteopathic Medicine - Rocky Vista Ƶ College of Osteopathic Medicine D.O.
    Undergraduate Ƶ of Oregon B.S.

    Selected Publications

    Journal Article

    1. Christensen V, Varnum M, Parker K, Chan LHK, Saxton L, Cottrell E (2024). The Impact of Structural and Meso-Level Factors on Caregiver Coping Abilities When Supporting a Child with Cancer: A Qualitative Study. Int J Environ Res Public Ƶ, 21(7). ()
    2. D Beeler, V Christensen, K Parker and E Cottrell (2023). "The place it puts us in emotionally and relationally with our Ƶ, it's damaging": understanding the real world psychosocial needs of caregivers and Ƶhood cancer survivors . J Cancer Surviv.
    3. Parker K, Durben N, Oleson D, Yu Y, Lim J, Recht M, Lindemulder S (2023). Hopping As an Indicator of Chemotoxicity: Gait Analysis in Patients with Leukemia and Lymphoma. Journal of Pediatric Hematology/Oncology, 45.
    4. Parker K, Christensen V, Lindemulder S, Chan L, Saxton L, Cottrell E (2023). Family Perspectives on the Transition from Active Treatment to Survivorship for Children with Cancer. Pediatr Blood Cancer.
    5. Ou JL, Bennion N, Parker KN, Fair D, Hanson HA, Kepka DL, Warner EL, Ramsay JM, Kaddas HK, Kirchhoff AC (2023). Risk factors for HPV-associated subsequent malignant neoplasms among adolescent and young adult survivors   . Cancer Epidemiol Biomarkers Prev, 32(5), 625-633.
    6. Christensen V, Parker K, Chan K, Saxton L, Cottrell E (2022). ‘Never once was I thinking the c‐word’: Parent perspectives on the facilitators and barriers to getting a Ƶhood cancer diagnosis. J Clin Nurs.
    7. Christensen V, Parker K, Cottrell E (2021). Leveraging a qualitative data repository to integrate patient and caregiver perspectives into clinical research. J Clin Transl Sci, 5(1), e155. ()
    8. Parker K, Cottrell E, Stork L, Lindemulder S (2021). Parental decision making regarding consent to randomization on Children's Oncology Group AALL0932. Pediatr Blood Cancer.

    Letter

    1. Lucero OM, Parker K, Funk T, Dunlap J, Press R, Gardner RA, Chang BH (2019). Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure. [Letter to the editor]. Br J Haematol, 186(2), 333-336. ()